Viral Production and CRISPR Engineering
Viral Production and CRISPR Engineering
批准号:
10709406
负责人:
Derek Stuart Welsbie
金额:
$8.86万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2028-04-30
关键词:
Age related macular degenerationBase PairingCRISPR-mediated transcriptional activationCRISPR/Cas technologyCell Culture TechniquesCellsCenter Core GrantsClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesComplementary DNACulture SetupDedicationsDependovirusDevelopmentDiseaseDisease modelEngineeringEquipmentEyeEye diseasesFacultyGenesGeneticGenomeGenome engineeringGlaucomaGuide RNAHuman GeneticsHuman ResourcesInvestmentsLentivirusLentivirus VectorMediatingMutagenesisProductionProteinsRNA SequencesReagentRegulatory ElementRodent ModelServicesSuspensionsSystemTechnologyTherapeuticTimeTranscription CoactivatorTranscription RepressorViralVision researchWritingadeno-associated viral vectorcostdigitalfast protein liquid chromatographyfunctional genomicsgain of functiongene functionin vivoinherited retinal degenerationloss of functionnovelrepairedscreeningtoolvectorviral gene delivery
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Viral Production and CRISPR Engineering Core
The NEI UCSD Center Core Grant for Vision Research Viral Production and CRISPR Engineering Core is
focused on the production of adeno-associated virus (AAV) and lentivirus (LV) vectors to allow for genome
engineering in vivo. Over the last several years, Shiley Eye Institute faculty have been heavily invested in
using genetic tools like high-throughput functional genomic screening (e.g., Wahlin and Welsbie) and
human genetics (e.g., Weinreb, Ayyagari, Borooah) to identify genes involved in various ophthalmic
diseases, including glaucoma, age-related macular degeneration (AMD) and inherited retinal degenerations
(IRDs). To be able to study the function of these genes in rodent models of disease, it is necessary to
produce gain-of-function (GOF) and loss-of-function (LOF) conditions. By fusing Cas9 to transcriptional
activators and repressors, technologies like CRISPR activation (CRISPRa) and inhibition (CRISPRi), as well
as conventional Cas9-mediated mutagenesis, can be used to produce the necessary GOF and LOF
conditions. Moreover, novel CRISPR technologies are being developed therapeutically to edit specific base
pairs or rewrite larger sections of genome using homology-directed repair (HDR). The key to all of these is
the viral delivery of genes encoding these large Cas9 proteins as well as optimized guide RNAs (gRNAs)
that direct Cas9. Finally, AAV can be used to express cDNAs (independent of CRISPRs). In all cases,
faculty are using a variety of outside cores for AAV production, resulting in high costs, variable quality and
only a limited selection of reagents. The Viral Production and CRISPR Engineering Core has access to
compact regulatory elements that can be used to create all-in-one AAV vectors that deliver Cas9 as well as
guide RNAs. The Core has a suspension cell culture setup, AAV and LV HEK293F producer cells, Cytiva
AKTA Pure fast protein liquid chromatography (FPLC) system and BioRad digital droplet PCR (ddPCR)
system for AAV/LV production, purification and titering. There is a dedicated part-time technician and
extensive know-how regarding AAV and CRISPR engineering that will be available to faculty.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinase Multitargeting for Glaucoma Neuroprotection
-
批准号:10426103
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2018
-
负责人:Derek Stuart Welsbie
-
依托单位:
Kinase Multitargeting for Glaucoma Neuroprotection
-
批准号:10675240
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2018
-
负责人:Derek Stuart Welsbie
-
依托单位:
Kinase Multitargeting for Glaucoma Neuroprotection
-
批准号:9764369
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2018
-
负责人:Derek Stuart Welsbie
-
依托单位:
Kinase Multitargeting for Glaucoma Neuroprotection
-
批准号:10200067
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2018
-
负责人:Derek Stuart Welsbie
-
依托单位:
An RNAi Screen for Genes that Modulate Retinal Ganglion Cell Survival
-
批准号:8359226
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2012
-
负责人:Derek Stuart Welsbie
-
依托单位:
An RNAi Screen for Genes that Modulate Retinal Ganglion Cell Survival
-
批准号:8539490
-
项目类别:
-
资助金额:$15.39万
-
财政年份:2012
-
负责人:Derek Stuart Welsbie
-
依托单位:
High-content high-throughput functional genomics in rodent retinal ganglion cells
-
批准号:8391700
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2011
-
负责人:Derek Stuart Welsbie
-
依托单位:
High-content high-throughput functional genomics in rodent retinal ganglion cells
-
批准号:8735206
-
项目类别:
-
资助金额:$3.17万
-
财政年份:2011
-
负责人:Derek Stuart Welsbie
-
依托单位:
High-content high-throughput functional genomics in rodent retinal ganglion cells
-
批准号:8225961
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2011
-
负责人:Derek Stuart Welsbie
-
依托单位:
High-content high-throughput functional genomics in retinal ganglion cells
-
批准号:8979693
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2011
-
负责人:Derek Stuart Welsbie
-
依托单位:
High-content high-throughput functional genomics in retinal ganglion cells
-
批准号:8780632
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2011
-
负责人:Derek Stuart Welsbie
-
依托单位:
High-content high-throughput functional genomics in rodent retinal ganglion cells
-
批准号:8620657
-
项目类别:
-
资助金额:$23.19万
-
财政年份:2011
-
负责人:Derek Stuart Welsbie
-
依托单位:
海外基金